Chlorambucil as a steroid-sparing agent in bullous pemphigoid [3]

British Journal of Dermatology

Volumn 151, Issue 5, 2004, Pages 1107-1108

  Chave, T A ^a   Mortimer, N J ^a   Shah, D S ^a   Hutchinson, P E ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; STEROID;

BLISTER; BULLOUS SKIN DISEASE; HUMAN; LETTER; PEMPHIGOID; PRIORITY JOURNAL; PRURITUS; URTICARIA;

AGED; AGED, 80 AND OVER; CHLORAMBUCIL; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PREDNISOLONE; RETROSPECTIVE STUDIES;

EID: 9644255758     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06241.x     Document Type: Letter

References (7)

1. Lever WF. Pemphigus. Medicine 1953; 32: 2-123.
2. Khumalo NP, Murrell DF, Wojnarowska F et al. A systematic review of the treatments for bullous pemphigoid. Arch Dermatol 2002; 138: 385-9.
3. Wojnarowska F, Kirtschig G, Highet AS et al. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002; 147: 214-21.
4. Joly P, Roujeau JC, Benichou J et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002; 346: 321-7.
5. Milligan A, Hutchinson PE. The use of chlorambucil in the treatment of bullous pemphigoid. J Am Acad Dermatol 1990; 22: 796-801.
6. Palmer RG, Denman AM. Malignancies induced by chlorambucil. Cancer Treat Rev 1984; 11: 121-9.
7. Seidenfeld AM, Smythe HA, Ogryzio MA et al. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. J Rheumatol 1976; 3: 295-304.